With the strike of COVID-19 global pharma events, including DIA, OCT and BIO, kept their events virtual in 2020 and 2021. However, now, with some restrictions lifted people start looking forward to having more face-to-face interaction, while getting tired of virtual events. In this episode we host Josh Karanasios, the founder of Jam55, who will share his projections on what Pharma and CRO networking will look like in 2022.
